Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Vaccine|March 7, 2006
A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in miceAviva Joseph, Noga Itskovitz-Cooper, Sarit Samira, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Enhanced recognition of human NK receptors after influenza virus infectionHagit Achdout, Tal I Arnon, Gal Markel, et al.Vaccine|September 6, 2002
Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccinesAviva Joseph, Igal Louria-Hayon, Alla Plis-Finarov, et al.Journal of Medical Virology|February 26, 2003
Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adultsArie Ben-Yehuda, Aviva Joseph, Evelyne Zeira, et al.Plos One|December 10, 2009
Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient miceScott G Kitchen, Michael Bennett, Zoran Galić, et al.The Journal of Cell Biology|December 24, 2015
In vivo single-particle imaging of nuclear mRNA export in budding yeast demonstrates an essential role for Mex67pCarlas Smith, Azra Lari, Carina Patrizia Derrer, et al.Vaccine|January 22, 2011
A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticityOrli Even-Or, Aviva Joseph, Noga Itskovitz-Cooper, et al.Blood|September 25, 2003
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46Tal I Arnon, Hagit Achdout, Niva Lieberman, et al.Vaccine|June 14, 2003
Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residentsArie Ben-Yehuda, Aviva Joseph, Yechezkel Barenholz, et al.Journal of Virology|January 11, 2008
Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activityAviva Joseph, Jian Hua Zheng, Antonia Follenzi, et al.Pageof 3